Skip to main content
. 2020 Nov 4;303(1):181–188. doi: 10.1007/s00404-020-05801-1

Fig. 3 .

Fig. 3 

Illustration of wound dehiscence in a patient from the TissuGlu® group with recurrent wound infections and consecutive revision after the end of the follow-up period